DCR-LLY-10

N/A

Report date: 2022/01/29 14:52:44
NME

Base Information

Drug NameDCR-LLY-10
Drug Alias NameDCR-LLY-10
ClassificationOther
Mechanisms of ActionRNA interference
TargetsUpdating
Therapy Area/IndicationsPainMetabolic DiseasesCardiovascular Diseases +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDicerna Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesDicerna Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsPainMetabolic DiseasesCardiovascular Diseases +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A